NYU Bladder Cancer Symposium Update on Medical and Surgical Management for the Urologist 2022

NYU Langone Health Bladder Cancer Symposium Update on Medical and Surgical Management for the Urologist 2022

Format: 12 videos + 1 pdf, size: 1.51 GB

Course Audience: urologists

Overview:

March 11, 2022 9:45 AM – 4:30 PM

The diagnosis and management of urothelial cell carcinoma of the bladder have been greatly influenced by recent medical, immunologic, surgical, and technological advances. One of the greatest challenges of the practicing urologist is to stay abreast with the many dynamic changes in this field. A nationally acclaimed faculty has been assembled to provide this update with presentations on topics such as diagnosis and management of non-muscle invasive bladder cancer (NMIBC); novel therapies for high-risk NMIBC including vaccines and clinical trials; immunologic approaches for the treatment of bladder cancer; technical advances in surgical treatment, bladder preservation, and reconstructive surgery. During the plenary sessions and state-of-the-art lectures, the registrants will have the opportunity to participate in question and answer sessions. In addition, an emphasis on case presentations with faculty participation will enhance the practical value of the course.

Course Description

The diagnosis and management of urothelial cell carcinoma of the bladder have been greatly influenced by recent medical, immunologic, surgical, and technological advances. One of the greatest challenges of the practicing urologist is to stay abreast with the many dynamic changes in this field. A nationally acclaimed faculty has been assembled to provide this update with presentations on topics such as diagnosis and management of non-muscle invasive bladder cancer (NMIBC); novel therapies for high-risk NMIBC including vaccines and clinical trials; immunologic approaches for the treatment of bladder cancer; technical advances in surgical treatment, bladder preservation, and reconstructive surgery. During the plenary sessions and state-of-the-art lectures, the registrants will have the opportunity to participate in question and answer sessions. In addition, an emphasis on case presentations with faculty participation will enhance the practical value of the course.

Educational Objectives

After participating in this activity, clinicians should be able to:

1. Discuss and analyze recent clinical evidence supporting implementing immunotherapy in bladder cancer
2. Recognize indications and describe best practices for surgical management, reconstruction, and bladder preservation for patients with invasive bladder cancer
3. Describe new approaches to medical therapy of bladder cancer
4. Describe similarities and differences of urothelial cell carcinoma of the bladder and upper urinary tract

Target Audience

Urologists and Urologic Trainees (Residents and Fellows)

 

Agenda (PDF Format)

Bladder Preservation for Muscle Invasive Bladder Cancer (Video TS Format)

Checkpoint Inhibitors in the Treatment of NMIBC (Video TS Format)

Complications of Radical Cystectomy Management Strategies (Video TS Format)

Intravesical BCG Update on State of the Art (Video TS Format)

Novel Therapies for BCG Unresponsive High Risk NMIBC (Video TS Format)

Quality Indicators and Enhanced Imaging in Cystoscopy and TURBT Detection (Video TS Format)

Radical Cystectomy Open Versus Robotic (Video TS Format)

Treatment of Advanced Metastatic Urothelial Cancer in the Urologist Clinic (Video TS Format)

Treatment of Locally Advanced Urothelial Cell Carcinoma Neoadjuvant and Adjuvant Therapy (Video TS Format)

Treatment Surveillance Algorithms AUA NMIBC Guidelines 2020 (Video TS Format)

Update of Upper Tract Urothelial Carcinoma (Video TS Format)

Updated Treatment of Advanced Metastatic Urothelial Cancer (Video TS Format)